Beauty Health Co Stock: price and management transactions · United States · SEC (Form 4)Follow the Beauty Health Co share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Beauty Health Co has recorded 115 insider filings. Market capitalisation: €97.8m. The latest transaction was disclosed on 13 April 2026 (Retenue fiscale). Among the most active insiders: MONAHAN MICHAEL P.. All data is free.
Analyst consensus: bullish or bearish? Analysts rate Beauty Health Co Hold (neutral), based on 6 analysts. Average price target: US$1.34.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,950 of 29,064 companies
FCF yld 38%
Earn yld -11%
EV/EBITDA 12.0x
ROE -12%
Gross mgn 65%
Net mgn -3.2%
Debt/EBITDA 9.8x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 April 2026
All Executives115 Thresholds0 Prospectus0 Other0
Declarations 115 total
● Chief Financial Officer · Executives · 9 Apr 2026
26,776 shares @ US$0.92 2.3% of flow Class A Common Stock SEC:0001628280-26-024900:0
● CSO and COO · Executives · 9 Apr 2026
24,904 shares @ US$0.92 2.4% of flow Class A Common Stock SEC:0001628280-26-024902:0
◆ CSO and COO · Executives · 20 Mar 2026
746,681 shares Class A Common Stock SEC:0001628280-26-020847:0
◆ Chief Revenue Officer · Executives · 20 Mar 2026
746,681 shares Class A Common Stock SEC:0001628280-26-020848:0
◆ President and CEO · Executives · 20 Mar 2026
2,654,867 shares Class A Common Stock SEC:0001628280-26-020850:0
◆ Chief Financial Officer · Executives · 20 Mar 2026
746,681 shares Class A Common Stock SEC:0001628280-26-020849:0
● CSO and COO · Executives · 17 Mar 2026
51,883 shares @ US$1.17 6.0% of flow Class A Common Stock SEC:0001628280-26-019785:0
● Chief Revenue Officer · Executives · 17 Mar 2026
61,471 shares @ US$1.17 7.5% of flow Class A Common Stock SEC:0001628280-26-019783:0
● Chief Financial Officer · Executives · 17 Mar 2026
58,573 shares @ US$1.17 5.6% of flow Class A Common Stock SEC:0001628280-26-019782:0
◆ Director · Executives · 13 Nov 2025
57,692 shares Class A Common Stock SEC:0001628280-25-052601:0
● Chief Revenue Officer · Executives · 1 Nov 2025
46,426 shares @ US$1.43 6.4% of flow Class A Common Stock SEC:0001628280-25-048959:0
◆ President and CEO · Executives · 9 Oct 2025
1,228,846 shares @ US$1.56 100.0% of flow Class A Common Stock SEC:0001628280-25-044806:0
● Chief Financial Officer · Executives · 10 Aug 2025
32,357 shares @ US$1.89 4.9% of flow Class A Common Stock SEC:0001628280-25-039897:0
◆ Director · Executives · 16 Jun 2025
73,051 shares Class A Common Stock SEC:0001628280-25-032138:0
◆ Director · Executives · 16 Jun 2025
73,051 shares Class A Common Stock SEC:0001628280-25-032142:0
◆ Director · Executives · 16 Jun 2025
73,051 shares Class A Common Stock SEC:0001628280-25-032141:0
◆ Director · Executives · 16 Jun 2025
73,051 shares Class A Common Stock SEC:0001628280-25-032140:0
◆ Director · Executives · 16 Jun 2025
73,051 shares Class A Common Stock SEC:0001628280-25-032139:0
◆ Director · Executives · 16 Jun 2025
73,051 shares Class A Common Stock SEC:0001628280-25-032135:0
● Chief Financial Officer · Executives · 1 Jun 2025
24,290 shares @ US$1.63 3.7% of flow Class A Common Stock SEC:0001628280-25-029044:0
● CSO and COO · Executives · 9 Apr 2025
31,296 shares @ US$1.08 3.8% of flow Class A Common Stock SEC:0001628280-25-017556:0
● Chief Financial Officer · Executives · 9 Apr 2025
26,776 shares @ US$1.08 2.9% of flow Class A Common Stock SEC:0001628280-25-017546:0
● President and CEO · Executives · 9 Apr 2025
92,981 shares @ US$1.08 3.6% of flow Class A Common Stock SEC:0001628280-25-017550:0
◆ President and CEO · Executives · 17 Mar 2025
1,832,386 shares @ US$1.32 88.3% of flow Class A Common Stock SEC:0001628280-25-013882:0
◆ Chief Revenue Officer · Executives · 17 Mar 2025
639,204 shares @ US$1.32 100.0% of flow Class A Common Stock SEC:0001628280-25-013884:0
25 of 115 declarations
Load more (90 remaining) 关于 Beauty Health Co Beauty Health Co(股票代码:SKIN)是一家总部位于美国的纳斯达克上市公司。它在医疗美容和美容领域运营,专注于专业的皮肤健康体验。公司总部位于美国加利福尼亚州长滩。其目前的法人结构可追溯到 2021 年 5 月与 Vesper Healthcare Acquisition Corp. 完成的业务合并,该合并使公司作为专注于品类的皮肤健康平台进入公开市场。
在运营方面,Beauty Health 以其旗舰品牌 Hydrafacial 而闻名,这是一种领先的水磨皮系统,通过办公室治疗清洁、提取和滋润皮肤。该公司还销售 SkinStylus(专注于纳米微针和微针)和 Keravive(一种头皮健康产品)。Beauty Health 设计、开发、制造、营销和销售美容技术和产品。对于投资者而言,该模式值得关注,因为它将资本设备与一次性吸头、精华液和治疗解决方案等经常性消耗品相结合,从而创造出比纯粹的产品型美容品牌更持久的收入流。
从竞争角度来看,Beauty Health 在专业护肤领域占据了利基高端地位。其差异化优势来自于 Hydrafacial 强大的品牌认知度、广泛的供应商生态系统以及与护肤合作伙伴合作共同推出产品的能力。该公司的定位融合了美学、健康和医疗技术风格的治疗交付,这有助于它吸引不同年龄段、皮肤类型和肤色的广泛受众。这种创造品类的叙事仍然是其股权故事的核心。
Beauty Health 的地理足迹遍布全球。该公司在全球销售和部署其系统,并服务于全球美容师、医疗水疗中心和专业治疗提供商网络。其战略强调扩大交付系统的安装基础,同时增加消耗品销售并加强现有和新地区的品牌知名度。
最新的公司披露和投资者沟通表明,公司持续强调国际扩张、运营优化以及新产品和合作伙伴活动。近期,管理层强调了扩大全球足迹、提高基础设施效率以及通过创新和社区投资支持核心 Hydrafacial 特许经营权的努力。对于国际股票投资者而言,SKIN 是纳斯达克上市的美国成长型公司,其业绩高度依赖于执行力、品牌实力以及将已安装系统转化为经常性消耗品需求的能力。